Martin Shkreli's one-time turnaround project, KaloBios, files for bankruptcy reorganization

KaloBios Pharmaceuticals Inc. — the pet project of indicted former hedge fund manager and drug industry executive Martin Shkreli — filed late Tuesday for Chapter 11 bankruptcy reorganization...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.